These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
261 related items for PubMed ID: 29649671
1. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 - A ten-year overview. Willems LM, Richter S, Watermann N, Bauer S, Klein KM, Reese JP, Schöffski O, Hamer HM, Knake S, Rosenow F, Strzelczyk A. Epilepsy Behav; 2018 Jun; 83():28-35. PubMed ID: 29649671 [Abstract] [Full Text] [Related]
2. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany. Strzelczyk A, Haag A, Reese JP, Nickolay T, Oertel WH, Dodel R, Knake S, Rosenow F, Hamer HM. Epilepsy Behav; 2013 Jun; 27(3):433-8. PubMed ID: 23591262 [Abstract] [Full Text] [Related]
3. Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany. Hamer HM, Spottke A, Aletsee C, Knake S, Reis J, Strzelczyk A, Oertel WH, Rosenow F, Dodel R. Epilepsia; 2006 Dec; 47(12):2165-72. PubMed ID: 17201718 [Abstract] [Full Text] [Related]
5. Evaluation of costs of epilepsy using an electronic practice management software in Germany. Noda AH, Hermsen A, Berkenfeld R, Dennig D, Endrass G, Kaltofen J, Safavi A, Wiehler S, Carl G, Meier U, Elger CE, Menzler K, Knake S, Rosenow F, Strzelczyk A. Seizure; 2015 Mar; 26():49-55. PubMed ID: 25799902 [Abstract] [Full Text] [Related]
6. Evaluation of health-care utilization among adult patients with epilepsy in Germany. Strzelczyk A, Nickolay T, Bauer S, Haag A, Knake S, Oertel WH, Reif PS, Rosenow F, Reese JP, Dodel R, Hamer HM. Epilepsy Behav; 2012 Apr; 23(4):451-7. PubMed ID: 22381385 [Abstract] [Full Text] [Related]
10. Trends in resource utilization and cost of illness in patients with active epilepsy in Germany from 2003 to 2020. Willems LM, Hochbaum M, Zöllner JP, Schulz J, Menzler K, Langenbruch L, Kovac S, Knake S, von Podewils F, Hamacher M, Hamer HM, Reese JP, Frey K, Rosenow F, Strzelczyk A. Epilepsia; 2022 Jun; 63(6):1591-1602. PubMed ID: 35305026 [Abstract] [Full Text] [Related]
11. Management of focal epilepsy in adults treated with polytherapy in France: the direct cost of drug resistance (ESPERA study). de Zélicourt M, de Toffol B, Vespignani H, Laurendeau C, Lévy-Bachelot L, Murat C, Fagnani F. Seizure; 2014 May; 23(5):349-56. PubMed ID: 24560531 [Abstract] [Full Text] [Related]
12. Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: An analysis from the National Health and Wellness Survey. Gupta S, Kwan P, Faught E, Tsong W, Forsythe A, Ryvlin P. Epilepsy Behav; 2016 Feb; 55():146-56. PubMed ID: 26773686 [Abstract] [Full Text] [Related]
13. Clinical and economic burden of breakthrough seizures. Divino V, Petrilla AA, Bollu V, Velez F, Ettinger A, Makin C. Epilepsy Behav; 2015 Oct; 51():40-7. PubMed ID: 26255884 [Abstract] [Full Text] [Related]
14. Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam. Strzelczyk A, Schubert-Bast S, Reese JP, Rosenow F, Stephani U, Boor R. Epilepsy Behav; 2014 May; 34():86-91. PubMed ID: 24727467 [Abstract] [Full Text] [Related]
16. Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization. Manjunath R, Paradis PE, Parisé H, Lafeuille MH, Bowers B, Duh MS, Lefebvre P, Faught E. Neurology; 2012 Oct 30; 79(18):1908-16. PubMed ID: 23077014 [Abstract] [Full Text] [Related]
17. Cost of epilepsy care in a Nigerian tertiary hospital. Sanya EO, Kolo PM, Adekeye A, Mustapha K, Ademiluyi BA, Ajayi K. Niger Postgrad Med J; 2013 Dec 30; 20(4):266-71. PubMed ID: 24633267 [Abstract] [Full Text] [Related]